| # | % | |||||
|---|---|---|---|---|---|---|
| 501 | National Bank of Greece - ADR | 20 | 0 | 0.00% | ||
| 502 | LION BIOTECHNOLOGIES INC COM | 35 | 0 | 0.00% | ||
| 503 | ISHARES TR | 6 | 0 | 0.00% | ||
| 504 | ZIMMER BIOMET HLDGS INC | 8 | 0 | 0.00% | ||
| 505 | CONFORMIS INCORPORATED | 44 | 0 | 0.00% | ||
| 506 | ACADIA PHARMACEUTICALS INC COM | 6 | 0 | 0.00% | ||
| 507 | FIRST HORIZON CORPORATION COM | 44 | 0 | 0.00% | ||
| 508 | WYNDHAM WORLDWIDE CORP | 10 | 0 | 0.00% | ||
| 509 | DISCOVERY COMMUNICATNS NEW | 32 | 0 | 0.00% | ||
| 510 | TENAX THERAPEUTICS INC | 10 | 0 | 0.00% | ||
| 511 | CALAMOS STRATEGIC TOTL RETN | 7 | 0 | 0.00% | ||
| 512 | K2M GROUP HLDGS INC COM | 51 | 0 | 0.00% | ||
| 513 | HALYARD HEALTH INC | 18 | 0 | 0.00% | ||
| 514 | ISHARES TR | 6 | 0 | 0.00% | ||
| 515 | DYAX CORP COM CVR | 22 | 0 | 0.00% | ||
| 516 | NOAH HOLDINGS | 2 | 0 | 0.00% | ||
| 517 | INSMED INC | 15 | 0 | 0.00% | ||
| 518 | ISHARES | 21 | 0 | 0.00% | ||
| 519 | SEQUENOM INC | 50 | 0 | 0.00% | ||
| 520 | ULTRAGENYX PHARMACEUTICAL INC COM | 6 | 0 | 0.00% | ||
| 521 | VISHAY INTERTECHNOLOGY INC | 93 | 0 | 0.00% | ||
| 522 | SUNOPTA INC | 150 | 0 | 0.00% | ||
| 523 | Teladoc, Inc. | 36 | 0 | 0.00% | ||
| 524 | APACHE CORP | 10 | 0 | 0.00% | ||
| 525 | NEUROCRINE BIOSCIE COM USD0.001 | 7 | 0 | 0.00% | ||
| 526 | INOGEN INC COM | 18 | 0 | 0.00% | ||
| 527 | SAGE THERAPEUTICS INC | 5 | 0 | 0.00% | ||
| 528 | BLUCORA INC | 50 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001606587-19-000464, filed 2019.05.01).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
